Copyright © 2014 Quintiles

July 31, 2014

Second Quarter 2014 Earnings Call

2

Forward Looking Statements and Use of Non-GAAP Financial Measures

This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements reflect, among other things, the Company’s current expectations and anticipated results of operations, all of which are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, market trends or industry results to differ materially from those expressed or implied by such forward-looking statements. Therefore, any statements contained herein that are not statements of historical fact may be forward-looking statements and should be evaluated as such. Without limiting the foregoing, the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “should,” “guidance,” “targets,” “will” and the negative thereof and similar words and expressions are intended to identify forward-looking statements. Actual results may differ materially from the Company’s expectations due to a number of factors, including that most of the Company’s contracts may be terminated on short notice, the Company may be unable to maintain large customer contracts or to enter into new contracts, the Company may under-price its contracts, overrun its cost estimates, or fail to receive approval for or experience delays in documenting change orders, the historical indications of the relationship of backlog to revenues may not be indicative of their future relationship, the Company is subject to the complex and changing regulatory and international environments in which the Company operates, the Company may be unable to successfully identify, acquire and integrate businesses, the Company’s substantial indebtedness, and other risks more fully set forth in the Company's filings with the SEC, including the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2013, filed with the SEC on February 13, 2014, as such factors may be amended or updated from time to time in the Company’s periodic filings with the SEC, which are accessible on the SEC's website at www.sec.gov. The Company assumes no obligation to update any forward-looking statement after the date of this presentation, whether as a result of new information, future developments or otherwise.

This presentation includes financial measures not prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). Management believes that these non-GAAP financial measures provide useful supplemental information to management and investors regarding the underlying performance of the Company’s business operations and are more indicative of core operating results as they exclude certain items whose fluctuations from period-to-period do not necessarily correspond to changes in the core operations of the Company’s business. Investors and potential investors are encouraged to review the reconciliations of the non-GAAP financial measures to their most directly comparable GAAP measures attached to this presentation.

3

Second Quarter – New Business We continue to see strength in the market across both of our segments

• 21.2% net new business growth • 7 accounts that exceed $100 million or more in net new business • $10.26 billion of diversified backlog with over 500 pharmaceutical customers • Integrated Healthcare Services trailing 4 quarter book to bill ratio of 1.56

Net New Business Net New Business(billions of dollars) (billions of dollars)

Product Development $0.87 1.11x $1.87 1.21xIntegrated Healthcare Services

$0.36 1.42x $0.63 1.29x

Total $1.23 1.19x $2.50 1.23x

Three Months Ended June 30, 2014

Book-to-Bill Six Months Ended June 30, 2014

Book-to-Bill

4

Financial Highlights and Other Metrics

Second Quarter 2014 Highlights

8.6% constant currency service revenue growth and 9.7% at actual exchange rates IHS segment service revenue growth of 15.1% at constant currency and 15.6% at actual

exchange rates 14.4% growth in adjusted income from operations 60 basis points of expansion in adjusted income from operations margin 30.0% increase in Diluted Adjusted EPS

1 Diluted Adjusted EPS is represented in dollars.

Reconciliations of the non-GAAP measures adjusted income from operations, adjusted income from operations margin, adjusted EBITDA, adjusted net income attributable to Quintiles, and diluted adjusted earnings per share to the corresponding GAAP measures are attached in the Supplemental Information section of this presentation.

(millions of dollars) 2014 2013 Change 2014 2013 ChangeNet New Business 1,228.0$ 1,014.0$ 21.2% 2,503.0$ 2,259.0$ 10.8%Service Revenues 1,035.5$ 944.2$ 9.7% 2,040.8$ 1,871.7$ 9.0%Adjusted Income from Operations 141.9$ 124.1$ 14.4% 284.3$ 242.5$ 17.2%Adjusted Income from Operations Margin 13.7% 13.1% 60 bps 13.9% 13.0% 90 bpsAdjusted EBITDA 171.8$ 149.1$ 15.2% 343.2$ 292.1$ 17.5%Adjusted Net Income Attributable to Quintiles 85.7$ 62.9$ 36.2% 176.7$ 120.5$ 46.6%Diluted Adjusted EPS1 0.65$ 0.50$ 30.0% 1.33$ 0.98$ 35.7%

Three Months Ended June 30 Six Months Ended June 30

5

Segment Performance

Service Revenues and Income from Operations

$ M

illio

ns

$ M

illio

ns

Product Development

0

200

400

600

800 $781.2 $724.2

$158.4 $136.1

0

200

400

600 $488.8 $441.2

$ M

illio

ns

0

100

200

300 $254.3 $220.0

$11.7 $ M

illio

ns

Integrated Healthcare Services

Certain costs are not allocated to the Company’s segments and are reported as general corporate and unallocated expenses. These costs primarily consist of share-based compensation and expenses for corporate overhead functions such as finance, human resources, information technology, facilities and legal. The Company does not allocate restructuring or impairment charges to its segments.

0

500

1,000

1,500

2,000 $1,552.0 $1,430.5

$319.0 $268.8

Actual Constant1 Actual Constant1

Revenue Growth 7.9% 6.7% Revenue Growth 15.6% 15.1% Operating Income Growth 16.4% 11.3% Operating Income Growth (6.4%) 3.7%

Actual Constant1 Actual Constant1 Revenue Growth 8.5% 7.6% Revenue Growth 10.8% 11.5% Operating Income Growth 18.7% 12.0% Operating Income Growth 10.1% 21.2%

1The constant currency calculation is provided in the Supplemental Information section of this presentation.

Thre

e M

onth

s En

ded

June

30

Six

Mon

ths

Ende

d

June

30

Thre

e M

onth

s E

nded

J

une

30

Six

Mon

ths

Ende

d Ju

ne 3

0

$12.5

$20.7 $18.7

2014 2013

Operating Income Margin 20.3% 18.8% Operating Income Margin 4.6% 5.7%

2014 2013

Operating Income Margin 20.6% 18.8% Operating Income Margin 4.2% 4.3%

Revenues Operating Income

6

2014 Guidance Update

Service Revenues range of $4.20 billion to $4.24 billion

• 10.3% to 11.3% year over year growth range at forecasted exchange rates

Diluted Adjusted Earnings per share range of $2.57 to $2.67

• 22.4% to 27.1% year over year growth range at forecasted exchange rates

Annual Effective Income Tax Rate of approximately 30%

This financial guidance is based on the actual results for the first six month period of 2014 combined with our estimates for the following six months of 2014, assuming the June foreign currency exchange rates stay in effect for the remainder of the year and does not reflect the impact of any future equity repurchases. A reconciliation of forecasted diluted adjusted earnings per share to diluted GAAP net income per share is provided in the Supplemental Information section of this presentation.

1

1

7

Summary • Good 2014 first half year results

• Capital deployment achievements

• Recognition during the quarter

IHS returned to growth with 11.5% constant currency service revenue growth

Product Development executed consistently with good revenue growth and improved productivity

Consolidated net new business growth of 10.8% 90 bps of adjusted operating margin expansion 35.7% diluted adjusted EPS growth RFP pipeline strong

Purchased 3.3 million shares Announced acquisition of Encore Health Resources

acquisition and closed on July 1, 2014

Named to the Fortune 500 Recognized as the Industry Leader in Phase I and

Phase IV by ISR Computerworld’s 100 Best Places to Work - 6th time Named to CIO 100 for Quintiles Infosario® platform Britain’s Healthiest Large Workplace Great Place to Work awards Europe and the UK

1

2

3

8

Supplemental Information Constant Currency Reconciliation Contractual Revenue Currency Mix and Foreign Exchange Analysis Income Statement Non-GAAP Reconciliation Adjusted EBITDA Reconciliation Adjusted Net Income and EPS Reconciliation Non-GAAP 2014 Guidance Reconciliation

9

Constant Currency Reconciliation Service Revenues and Income from Operations

Service revenues exchange impact equals the current period service revenues at actual rates less the current period service revenues for foreign currency denominated contracts recalculated at the prior period exchange rates, while the exchange rate impacts on expenses equals the current period expenses at actual rates less the current period expenses recalculated at the prior period exchange rates. The segment detail presented above excludes general corporate and unallocated expenses and restructuring costs.

(millions of dollars)

Consolidated ActualExchange

Impact Constant ActualExchange

Impact Constant Service Revenues 1,035.5$ 10.1$ 1,025.4$ 9.7% 1.1% 8.6%Income from Operations 141.0$ 5.7$ 135.3$ 48.6% 6.0% 42.6%Adjusted Income from Operations 141.9$ 5.7$ 136.2$ 14.4% 4.5% 9.9%Adjusted Income from Operations Margin 13.7% 13.3%

Product DevelopmentService Revenues 781.2$ 8.9$ 772.3$ 7.9% 1.2% 6.7%Income from Operations 158.4$ 6.9$ 151.5$ 16.4% 5.1% 11.3%Income from Operations Margin 20.3% 19.6%

Integrated Healthcare ServicesService Revenues 254.3$ 1.2$ 253.1$ 15.6% 0.5% 15.1%Income from Operations 11.7$ (1.2)$ 12.9$ (6.4%) -10.1% 3.7%Income from Operations Margin 4.6% 5.1%

Three Months Ended June 30 Year on Year Growth

(millions of dollars)

Consolidated ActualExchange

Impact Constant ActualExchange

Impact Constant Service Revenues 2,040.8$ 9.6$ 2,031.2$ 9.0% 0.5% 8.5%Income from Operations 282.3$ 15.9$ 266.4$ 34.4% 7.6% 26.8%Adjusted Income from Operations 284.3$ 15.9$ 268.4$ 17.2% 6.5% 10.7%Adjusted Income from Operations Margin 13.9% 13.2%

Product DevelopmentService Revenues 1,552.0$ 12.6$ 1,539.4$ 8.5% 0.9% 7.6%Income from Operations 319.0$ 17.9$ 301.1$ 18.7% 6.7% 12.0%Income from Operations Margin 20.6% 19.6%

Integrated Healthcare ServicesService Revenues 488.8$ (3.0)$ 491.8$ 10.8% -0.7% 11.5%Income from Operations 20.7$ (2.1)$ 22.8$ 10.1% -11.1% 21.2%Income from Operations Margin 4.2% 4.6%

Year on Year GrowthSix Months Ended June 30

10

Contractual Revenue Currency Mix and Foreign Exchange Analysis

1 Other includes a mix of more than 40 currencies.

USD Sterling Euro Yen Other1 Total2Q '14 $645.3 $84.3 $169.5 $107.6 $28.8 $1,035.5% of total 63% 8% 16% 10% 3% 100%

2Q '13 $582.7 $65.1 $161.5 $96.7 $38.2 $944.2% of total 62% 7% 17% 10% 4% 100%

2Q '14 Average Rate $1.66 $1.37 ¥102.772Q '13 Average Rate $1.54 $1.31 ¥98.75% Increase (Decrease) 7.8% 4.9% (3.9%)

Consolidated Service Revenues (millions of dollars)

USD Sterling Euro Yen Other1 TotalYTD 2014 $1,241.8 $175.8 $357.3 $210.2 $55.7 $2,040.8% of total 60% 9% 18% 10% 3% 100%

YTD 2013 $1,160.1 $140.3 $321.7 $192.4 $57.2 $1,871.7% of total 62% 7% 17% 10% 4% 100%

YTD '14 Average Rate $1.67 $1.37 ¥102.44YTD '13 Average Rate $1.54 $1.31 ¥95.52% Increase (Decrease) 8.1% 4.4% (6.7%)

Consolidated Service Revenues (millions of dollars)

11

Income Statement GAAP – Non-GAAP Reconciliation

1Represents the Company’s change in its permanent reinvestment assertion during 2Q 2013 retroactively applied to1Q 2013 for the new estimated annual effective income tax rate for 2013.

1

Six Months Ended June 30(millions of dollars)

Selling, General and

Administrative

Income from

Operations

Net Income Attributable to Quintiles

Selling, General and

Administrative

Income from

Operations

Net Income Attributable to Quintiles

As Reported $ 438.3 $ 282.3 $ 175.3 $ 428.1 $ 210.1 $ 86.8Adjustments

Restructuring Costs - 2.0 2.0 - 4.7 4.7 Management Fees - - - (27.7) 27.7 27.7 Loss on Extinguishment of Debt - - - - - 16.5 Tax Effect of Adjustments - - (0.6) - - (18.3) Other Income Tax Adjusments1 - - - - - 3.1 Adjusted Non-GAAP Basis $438.3 $284.3 $176.7 $400.4 $242.5 $120.5% of Service Revenues 21.5% 13.9% 8.7% 21.4% 13.0% 6.4%

2014 2013

Three Months Ended June 30(millions of dollars)

Selling, General and

Administrative

Income from

Operations

Net Income Attributable to Quintiles

Selling, General and

Administrative

Income from

Operations

Net Income Attributable to Quintiles

As Reported $ 219.0 $ 141.0 $ 85.1 $ 228.8 $ 94.9 $ 38.5Adjustments

Restructuring Costs - 0.9 0.9 - 2.8 2.8 Management Fees - - - (26.4) 26.4 26.4 Loss on Extinguishment of Debt - - - - - 16.5 Tax Effect of Adjustments - - (0.3) - - (17.1) Other Income Tax Adjusments1 - - - - - (4.2) Adjusted Non-GAAP Basis $219.0 $141.9 $85.7 $202.4 $124.1 $62.9% of Service Revenues 21.2% 13.7% 8.3% 21.4% 13.1% 6.7%

2014 2013

12

Reconciliation of Net Income Attributable to Quintiles to Non-GAAP Adjusted EBITDA

(millions of dollars) 2014 2013 2014 2013Net Income Attributable to Quintiles $ 85.1 $ 38.5 $ 175.3 $ 86.8

Income from Noncontrolling Interests - (0.1) - (0.3) Interest Expense, Net 23.8 31.1 47.3 66.7 Income Tax Expense 32.4 8.8 69.8 41.0 Depreciation and Amortization 29.9 25.0 58.9 49.6 Restructuring Costs 0.9 2.8 2.0 4.7 Management Fees - 26.4 - 27.7 Loss on Extinguishment of Debt - 16.5 - 16.5 Other Income 3.1 0.6 (1.8) (1.8) (Earnings) Losses from Unconsolidated Affiliates (3.4) (0.5) (8.3) 1.2

Non-GAAP Adjusted EBITDA $ 171.8 $ 149.1 $ 343.2 $ 292.1% of Service Revenues 16.6% 15.8% 16.8% 15.6%

Three Months Ended June 30 Six Months Ended June 30

13

Reconciliation of Net Income Attributable to Quintiles to Non-GAAP Adjusted Net Income and Diluted Adjusted EPS

1 EPS is represented in dollars. 2 The tax effect of adjustments was based on the income tax rate applicable to the respective transactions, which was 38.5%, with the exception of restructuring costs which were tax effected at 36.5% and 20.1% during the three months ended June 30, 2014 and 2013, respectively, and 30.3% and 26.4% during the six months ended June 30, 2014 and 2013, respectively.

3 Represents the Company’s change in its permanent reinvestment assertion during 2Q 2013 retroactively applied to1Q 2013 for the new estimated annual effective income tax rate for 2013.

4 Diluted shares are represented in thousands.

(millions of dollars) 2014EPS1 2013

EPS1 2014EPS1 2013

EPS1

Net Income Attributable to Quintiles $ 85.1 0.64$ $ 38.5 0.30$ $ 175.3 1.32$ $ 86.8 0.71$ Restructuring Costs 0.9 0.01 2.8 0.02 2.0 0.02 4.7 0.04 Management Fees - - 26.4 0.21 - - 27.7 0.23 Loss on Extinguishment of Debt - - 16.5 0.13 - - 16.5 0.13

Tax Effect of Adjustments2 (0.3) - (17.1) (0.13) (0.6) (0.01) (18.3) (0.15)

Other Income Tax Adjustments3 - - (4.2) (0.03) - - 3.1 0.02

Non-GAAP Adjusted Net Income $ 85.7 0.65$ $ 62.9 0.50$ $ 176.7 1.33$ $ 120.5 0.98$

Number of Diluted Shares Outstanding4 132,042 126,578 132,541 122,659

Three Months Ended June 30 Six Months Ended June 30

14

Non-GAAP 2014 Guidance Reconciliation

1 Restructuring costs are tax effected at approximately 30%.

1

Low High Low HighNet income attributable to Quintiles $328 - $344 $2.49 - $2.61Restructuring costs 14 - 12 0.11 - 0.09 Tax effect of adjustments (4) - (4) (0.03) - (0.03) Adjusted net income and diluted adjusted earnings per share $338 - $352 $2.57 - $2.67

Non-GAAP Adjusted Net Income

(millions of dollars)

Diluted Adjusted Earnings Per Share

1